Elipse Balloon from Allurion Technologies
Boston-based Allurion Technologies has raised $27 million in Series C funding to commercialize its intragastric balloon device. Contributors included current investor Romulus Capital, along with Cogepa Investments and IDO Investments.
“The funding…
Source: medcitynews.com – Read more

Gold Coast medical centre caught up in nationwide cyber attack – hottomato.com.au
Gold Coast medical centre caught up in nationwide cyber attack hottomato.com.au


